| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12031-014-0326-3 |
| P698 | PubMed publication ID | 24841086 |
| P50 | author | Semir Nouira | Q46172404 |
| P2093 | author name string | Kacem Mahdouani | |
| Sonia Hamdi | |||
| Khouloud Chehaibi | |||
| Mohamed Naceur Slimane | |||
| Mustapha Rouis | |||
| P2860 | cites work | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes | Q24290189 |
| PPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptor | Q24300059 | ||
| PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL | Q24311741 | ||
| The platelet in diabetes: focus on prevention of ischemic events | Q28196583 | ||
| A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis | Q28199913 | ||
| Leptin regulates proinflammatory immune responses | Q28565340 | ||
| Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies | Q44493587 | ||
| Economic costs of diabetes in the US in 2002. | Q44892463 | ||
| Peroxisome proliferator-activated receptor gamma C-161T polymorphism and carotid artery atherosclerosis in metabolic syndrome | Q44896842 | ||
| Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease | Q45107552 | ||
| PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity | Q45143033 | ||
| Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption | Q45154644 | ||
| Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus | Q46485449 | ||
| Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population. | Q46657347 | ||
| Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome | Q46685869 | ||
| The C161-->T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated | Q46777745 | ||
| Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome | Q46824955 | ||
| The 161TT genotype in the exon 6 of the peroxisome-proliferator-activated receptor gamma gene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers | Q47292130 | ||
| Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine | Q47579439 | ||
| Peroxisome proliferator-activated receptor gamma polymorphism is related to peak bone mass: the JPOS study | Q47684295 | ||
| Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse | Q48439792 | ||
| The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARγ) is associated with risk of coronary artery disease: a meta-analysis. | Q53111637 | ||
| Leptin is associated with increased risk of myocardial infarction. | Q54070456 | ||
| Predictors of Death and Vascular Events in the Elderly | Q57313142 | ||
| A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans | Q57606060 | ||
| Mortality From Cerebrovascular Disease in a Cohort of 23 000 Patients With Insulin-Treated Diabetes | Q62583517 | ||
| Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease | Q73482789 | ||
| Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes | Q74555870 | ||
| The nuclear receptor PPARgamma - bigger than fat | Q77485482 | ||
| Stroke in diabetic patients: is it really a macrovascular complication? | Q80838603 | ||
| PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression | Q81346957 | ||
| Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes | Q84744116 | ||
| The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis | Q87442713 | ||
| Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents | Q28573554 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 | ||
| PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus | Q33811239 | ||
| Verifying the stroke-free phenotype by structured telephone interview | Q33910376 | ||
| Leptin in the regulation of immunity, inflammation, and hematopoiesis | Q33922050 | ||
| Roles of PPARs in health and disease. | Q33934899 | ||
| Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview | Q34093891 | ||
| Report of the expert committee on the diagnosis and classification of diabetes mellitus | Q34167177 | ||
| Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors | Q34234016 | ||
| Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice | Q34430361 | ||
| Follow-up report on the diagnosis of diabetes mellitus | Q35567871 | ||
| Epidemiology of diabetes | Q35722893 | ||
| Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro | Q35753181 | ||
| Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study | Q35911582 | ||
| Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome | Q36101466 | ||
| Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective. | Q36296778 | ||
| Hypertension and cerebrovascular dysfunction | Q36777769 | ||
| Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature | Q37067129 | ||
| Management of hyperglycemia in acute stroke: how, when, and for whom? | Q37147631 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice | Q37242527 | ||
| Risk factors for ischaemic stroke. | Q37244553 | ||
| Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones | Q37271252 | ||
| Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids | Q37367423 | ||
| Differentiating ischemic stroke subtypes: risk factors and secondary prevention | Q37382595 | ||
| Significant synergistic effect of peroxisome proliferator-activated receptor gamma C-2821T and diabetes on the risk of ischemic stroke. | Q37400909 | ||
| Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications | Q37900621 | ||
| The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update | Q37970585 | ||
| The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease | Q38044273 | ||
| A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity | Q38331543 | ||
| No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects | Q40239471 | ||
| Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease | Q40753215 | ||
| Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology | Q41275255 | ||
| Aberrant angiogenesis: The gateway to diabetic complications | Q42373563 | ||
| Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort | Q43667388 | ||
| Serum leptin levels increase following acute myocardial infarction | Q43756044 | ||
| Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor | Q43819737 | ||
| Lack of association between peroxisome proliferator-activated receptor-gamma-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus | Q43935163 | ||
| UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. | Q44053922 | ||
| P433 | issue | 4 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 730-738 | |
| P577 | publication date | 2014-05-21 | |
| P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
| P1476 | title | Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus. | |
| P478 | volume | 54 |
| Q40717921 | PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong |
| Q35613936 | Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome |
| Q52368614 | Significant Association between OPG/TNFRSF11B Variant and Common Complex Ischemic Stroke. |
Search more.